Navigation Links
Urologists Begin Clinical Trials on Treatment of Peyronies Disease

Urologists have recently initiated large scale clinical trials in order to substantiate preliminary results. Pre-Trial Results The previous clinical studies by X4 Labs Inc. were a small scale study which not only looked at the effect of the device on penis curvature but also at its potential as a non-surgical penis enlargement product.

In the clinical trials conducted by the research and development firm, the penis extender was shown to correct Peyronies disease up to 70 percent and results were significantly higher in milder cases. The previous studies also showed significant promise for the penis extender as a non-surgical penile augmentation device.

The controlled sample indicated that males using the penis stretcher for approximately three to six months experienced an increase in penis size of approximately 2.5 inches, with minor variations amongst participants. Urological Trials to Be Conducted The previous clinical trials conducted by X4 Labs Inc. have led to a distinct interest by the urological community, particularly in the use of these devices as an alternative to traditional surgical procedures for the correction of penis curvature.

The penis extender works on the principle of traction, which in essence means that as tension is applied to the penis body it forces cellular division and the creation of new skin tissue. A clinical study will be launched in the upcoming months by the International Andrological Association aimed at substantiating the use of these devices on a wider scale.

As pervasive surgery on the penis can often have drastic side effects such as impotence and loss of sensitivity, the penis extender will be a valuable tool in mild cases of penis curvature. These results will allow for greater use of non-surgical penis extenders within urological clinics. Already medically certified, results of this study may increase urologists prescription of non-surgical devices for the treatment of mild cases of penile curvature.

For Mor Information Please Contact:- Adam Griffin, adam@enlargementworld.com


'"/>




Related medicine news :

1. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
2. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
3. Cancer Begins With Epigenetic Changes: Study
4. Learning About Healthy Diet Choices Begins At Schools
5. China Begins Human Trials For HIV/AIDS Drug
6. Pilot Study to Test Effect of Mobile Phone Transmissions On Skin To Begin In Finland
7. Preparation for Culling Begin at Belghat, Rajangaon and Dhaamnia
8. Make-Up Tips For Beginners
9. Jalgaon: Third Phase Of Culling Operations Begin
10. Human Bird Flu Vaccine Trials Begin In Russia
11. Administration of Fish Drug for Asthma Patients Begins in Andhra
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... City, NY (PRWEB) , ... March 29, 2017 ... ... for men’s and women’s professional squash, announced it has enlisted New York City-based ... The agency will develop and procure sponsorship opportunities for the Professional Squash ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
(Date:3/29/2017)... Illinois (PRWEB) , ... March 29, 2017 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... , NetZoom subscribers can request new equipment shapes for free and download shapes ...
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... treatment of a growing number of cancers and is touted to be the next ... of treatment, thus far, has been in the form of immune checkpoint inhibitors such ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... drugs market to grow at a CAGR of 2.87% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:3/29/2017)... Calif. , March 29, 2017 Varian Medical ... will report results for the second quarter of fiscal year ... 26, 2017.  The news release will be followed by a ... The news release and a link to the conference call ... www.varian.com/investor .  To access the teleconference call and replay: ...
(Date:3/29/2017)... 2017  Designers of primary cell wearable medical and ... 50% and extend battery life with the MAX20310 ultra-low ... (PMIC) from Maxim Integrated Products, Inc. (NASDAQ: ... voltage of just 0.7V for new high-energy density battery ... well as the more common Alkaline battery architecture. With ...
Breaking Medicine Technology: